psoriasis
Conditions
Interventions
treatment group:Qingbai Gel
control group:placebo
Sponsors
Guanganmen Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age between 18-65 years old. (2) Meets the diagnostic criteria for plaque psoriasis in a stable phase. (3) Patients with mild to moderate disease (BSA less than 10% PGA score of 2-3 see the evaluation criteria section for details). (4) Signed informed consent form.
Exclusion criteria
Exclusion criteria: (1) Individuals allergic to the active ingredients or excipients of this medication. (2) Women who are pregnant planning to become pregnant or breastfeeding. (3) Those who have used topical corticosteroids calcipotriol or retinoids within the past 2 weeks. (4) Individuals who have taken systemic corticosteroids immunosuppressants or retinoids within the past 4 weeks. (5) Patients who have received biological agent therapy within the past 36 weeks. (6) Patients with severe mental disorders or severe diseases of the cardiovascular cerebrovascular hepatic renal or hematopoietic systems. (7) Individuals with other severe skin conditions that may interfere with the clinical assessment of psoriasis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psoriasis Area and Severity IndexPASI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatology Life Quality Index,DLQI;Numerical Rating Scale NRS;Patient's Global Assessment,PaGA;Physician's Global Assessment,PGA; | — |
Countries
China
Contacts
Public ContactXu Chenchen
Guanganmen Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed